Jessica Tassan
Stock Analyst at Piper Sandler
(1.11)
# 3,877
Out of 5,124 analysts
79
Total ratings
31.82%
Success rate
-11.98%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Reiterates: Overweight | $99 → $101 | $79.36 | +27.27% | 6 | Dec 10, 2025 | |
| OSCR Oscar Health | Upgrades: Overweight | $13 → $25 | $14.37 | +73.97% | 7 | Nov 26, 2025 | |
| HNGE Hinge Health | Reiterates: Overweight | $70 → $71 | $46.45 | +52.85% | 2 | Nov 5, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $423 → $417 | $330.11 | +26.32% | 9 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Overweight | $33 → $34 | $16.92 | +100.95% | 6 | Sep 5, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $16 → $18 | $4.00 | +350.00% | 4 | Aug 28, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $8 → $4 | $2.39 | +67.36% | 12 | Aug 27, 2025 | |
| CTEV Claritev | Maintains: Overweight | $44 → $86 | $42.75 | +101.17% | 3 | Aug 15, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $69 | $44.28 | +55.83% | 4 | Aug 11, 2025 | |
| HUM Humana | Maintains: Neutral | $288 → $272 | $256.13 | +6.20% | 4 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $10 → $8 | $4.91 | +62.93% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $348 → $374 | $275.23 | +35.89% | 4 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $19.75 | +6.33% | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $12 | $7.00 | +71.43% | 6 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $45.30 | +54.53% | 4 | Aug 2, 2023 |
CVS Health
Dec 10, 2025
Reiterates: Overweight
Price Target: $99 → $101
Current: $79.36
Upside: +27.27%
Oscar Health
Nov 26, 2025
Upgrades: Overweight
Price Target: $13 → $25
Current: $14.37
Upside: +73.97%
Hinge Health
Nov 5, 2025
Reiterates: Overweight
Price Target: $70 → $71
Current: $46.45
Upside: +52.85%
UnitedHealth Group
Oct 29, 2025
Maintains: Overweight
Price Target: $423 → $417
Current: $330.11
Upside: +26.32%
Phreesia
Sep 5, 2025
Maintains: Overweight
Price Target: $33 → $34
Current: $16.92
Upside: +100.95%
Evolent Health
Aug 28, 2025
Maintains: Overweight
Price Target: $16 → $18
Current: $4.00
Upside: +350.00%
Health Catalyst
Aug 27, 2025
Downgrades: Neutral
Price Target: $8 → $4
Current: $2.39
Upside: +67.36%
Claritev
Aug 15, 2025
Maintains: Overweight
Price Target: $44 → $86
Current: $42.75
Upside: +101.17%
Doximity
Aug 11, 2025
Maintains: Overweight
Price Target: $65 → $69
Current: $44.28
Upside: +55.83%
Humana
Jul 31, 2025
Maintains: Neutral
Price Target: $288 → $272
Current: $256.13
Upside: +6.20%
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $4.91
Upside: +62.93%
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $275.23
Upside: +35.89%
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $19.75
Upside: +6.33%
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.00
Upside: +71.43%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $45.30
Upside: +54.53%